Marijuana laws by state
Cannabis statutes have moved further in the last 18 months than in the prior decade. SafestHires maintains this matrix so your drug-testing panel and policy language stay aligned with the off-duty-use protections that are now law in thirteen states and counting.
State-by-state cannabis treatment
| State | Legal status | Off-duty protection | Safety-sensitive carve-out | SafestHires note |
|---|---|---|---|---|
| California | Rec + Med | Yes — AB 2188 (2024) + SB 700 | DOT, federal contractors, construction (limited) | Non-psychoactive metabolite testing prohibited for hiring. |
| Colorado | Rec + Med | Limited (Coats v. Dish Network) | All safety-sensitive | Employers may enforce zero-tolerance policies. |
| Connecticut | Rec + Med | Yes — RERACA (CGS §21a-422) | Healthcare, mining, utilities, firearms, education | Written policy required to enforce. |
| Illinois | Rec + Med | Yes — CRTA (820 ILCS 55) | Safety-sensitive + federal mandate | Reasonable-suspicion test must be observable + documented. |
| Massachusetts | Rec + Med | Limited (Barbuto v. Advantage Sales) | Safety-sensitive | Reasonable accommodation analysis for medical patients. |
| Michigan | Rec + Med | No statewide statute; some local protections | All safety-sensitive | Public employees in DPD: 2024 MCOLES guidance allows hiring. |
| Minnesota | Rec + Med | Yes — 2023 Cannabis Act §181.953 | Safety-sensitive, healthcare, education, peace officers | Pre-employment testing prohibited for non-safety-sensitive roles. |
| Nevada | Rec + Med | Yes — AB 132 | First 30 days only; firefighters, EMTs, drivers excluded | Employers cannot fail an applicant solely on positive THC. |
| New Jersey | Rec + Med | Yes — CREAMM Act | DOT, federal contractor obligations | WIRE (Workplace Impairment Recognition Expert) certification framework. |
| New York | Rec + Med | Yes — Lab. Law §201-d | Safety-sensitive, federal mandate | Articulable symptoms of impairment required for testing. |
| Oregon | Rec + Med | No statewide off-duty protection | All | Off-duty use is not a protected activity under Oregon law despite legalization. |
| Rhode Island | Rec + Med | Yes — 2022 Cannabis Act | Safety-sensitive, federal mandate | Pre-employment screening for non-safety roles tightly limited. |
| Washington | Rec + Med | Yes — SB 5123 (eff. 2024) + SB 5793 (eff. 2026) | Safety-sensitive (narrowed 2026) + federal mandate + law enforcement | Pre-employment non-psychoactive metabolite testing prohibited; safety-sensitive carve-out narrowed by SB 5793 to roles where impairment poses risk of death or serious injury. |
What changed in the last 12 months
- California AB 2188 / SB 700 — full enforcement since Jan 1, 2024. Pre-employment urine THC testing is effectively prohibited for non-federally-regulated roles.
- Washington SB 5123 — non-psychoactive metabolite testing prohibited for hiring (Jan 1, 2024).
- Minnesota — reasonable-suspicion documentation under the 2023 Cannabis Act now actively scrutinized by MDHR.
- Delaware (HB 1) — adult-use cannabis rolled out 2025; employer off-duty rule still pending agency guidance.
- Washington SB 5793 — effective March 7, 2026, the safety-sensitive carve-out was narrowed to roles where impairment creates a substantial risk of death or serious bodily injury. Administrative, customer-service, and most professional roles no longer qualify.
- Maryland SB 439 (Chapter 183, 2026) — prohibits discriminatory employment actions against fire and rescue public safety employees for off-duty medical cannabis use, subject to fitness-for-duty conditions.
- New Jersey S3603 (pending, introduced Feb 2026) — proposes clarifying employer testing rights and expanding employee protections under CREAMM. Monitor before revising NJ policy language.
Panel design with SafestHires
We help clients move from 5-panel and 10-panel urinalysis to instant oral-fluid devices for safety-sensitive roles, and to "THC-out" panels for jurisdictions where pre-employment THC testing is restricted. The platform routes the correct panel to the correct collection-site network based on candidate work location automatically.
How to build a compliant cannabis testing policy
Six steps take a drug-testing program from a single national panel to a jurisdiction-aware policy that survives an off-duty-use challenge.
- Classify the role before you classify the panel. Decide whether the position is DOT-regulated, state-defined safety-sensitive, or neither. That single classification drives every other decision — and Washington's SB 5793 narrowed what counts as safety-sensitive in 2026.
- Check the work-state's off-duty protection. Use the matrix above. In protected states, a pre-employment THC screen on a non-safety-sensitive role is a liability, not a control.
- Swap the specimen or drop the analyte. Move safety-sensitive roles to instant oral-fluid collection, which detects recent use rather than stored metabolites, and run a THC-out panel everywhere pre-employment THC testing is restricted.
- Write the policy in the statute's own language. Connecticut and Illinois condition enforcement on having a written policy. Name the covered roles, the testing triggers, and the accommodation path for registered medical patients.
- Train supervisors on reasonable-suspicion documentation. Illinois, Minnesota, and New York require observable, articulable symptoms recorded at the time of observation. New Jersey adds the WIRE certification framework.
- Adverse-action a positive like any other report finding. A confirmed positive that is part of a consumer report follows the same FCRA pre-adverse and final adverse sequence, with the state's response window applied.
Frequently asked questions
Can employers still drug-test for marijuana?
Yes, in most states. But thirteen states — California, Connecticut, DC, Illinois, Maine, Minnesota, Montana, Nevada, New Jersey, New York, Rhode Island, Vermont, and Washington — restrict pre-employment testing or protect off-duty use, with safety-sensitive and federal-mandate carve-outs.
Do off-duty cannabis protection laws apply to DOT-regulated drivers?
No. Every state with an off-duty cannabis protection statute carves out DOT 49 CFR Part 40 testing and federally regulated safety-sensitive positions. DOT testing continues unchanged.
What changed in Washington under SB 5793?
Effective March 7, 2026, SB 5793 narrows Washington's safety-sensitive carve-out to roles where impairment poses a substantial risk of death or serious bodily injury. Administrative, customer-service, and most professional roles no longer qualify.
What is a non-psychoactive cannabis metabolite?
Carboxy-THC, the metabolite detected by standard urine THC tests, remains in the body for days or weeks after the psychoactive Δ9-THC has cleared. California (AB 2188) and Washington (SB 5123) treat the resulting positive as no evidence of impairment.
Can an employer still test after an accident or on reasonable suspicion?
Yes in every state on this matrix, but the documentation bar is higher. Illinois, Minnesota, and New York require observable, articulable symptoms of impairment recorded contemporaneously by a trained observer before a test is ordered.
Which state's cannabis rule applies to a remote employee?
Scope to the state where the employee performs the work. For hybrid or multi-state roles, most employers apply the most protective applicable rule and document that choice in the drug-testing policy.
Does a medical cannabis card require accommodation?
It depends on the state. Massachusetts (Barbuto), Connecticut, New Jersey, and several others require an interactive accommodation analysis for registered patients in non-safety-sensitive roles. Colorado and Oregon do not.